129 related articles for article (PubMed ID: 37919058)
41. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
42. Identification of immune-associated biomarker for predicting lung adenocarcinoma: bioinformatics analysis and experiment verification of PTK6.
Xiong RH; Yang SQ; Li JW; Shen XK; Jin LM; Chen CY; Yue YT; Yu ZC; Sun QY; Jiang W; Jiang MZ; Wang XY; Song SX; Cao D; Ye HL; Zhao LR; Huang LP; Bu L
Discov Oncol; 2024 Apr; 15(1):102. PubMed ID: 38573548
[TBL] [Abstract][Full Text] [Related]
43. NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma.
Wei S; Xing J; Lu K; Wang K; Yu W
Hereditas; 2023 May; 160(1):27. PubMed ID: 37254219
[TBL] [Abstract][Full Text] [Related]
44. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
[TBL] [Abstract][Full Text] [Related]
45. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
46. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
47. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma.
Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y
Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158
[TBL] [Abstract][Full Text] [Related]
48. High Expression of DLGAP5 Indicates Poor Prognosis and Immunotherapy in Lung Adenocarcinoma and Promotes Proliferation through Regulation of the Cell Cycle.
Tang X; Zhou H; Liu Y
Dis Markers; 2023; 2023():9292536. PubMed ID: 36712920
[TBL] [Abstract][Full Text] [Related]
49. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
50. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development.
Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C
BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325
[TBL] [Abstract][Full Text] [Related]
51. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
[TBL] [Abstract][Full Text] [Related]
52. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
53. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.
Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z
Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413
[TBL] [Abstract][Full Text] [Related]
54. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F
Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021
[TBL] [Abstract][Full Text] [Related]
55. Transducin Beta-Like 2 is a Potential Driver Gene that Adapts to Endoplasmic Reticulum Stress to Promote Tumor Growth of Lung Adenocarcinoma.
Kosai K; Masuda T; Kitagawa A; Tobo T; Ono Y; Ando Y; Takahashi J; Haratake N; Kohno M; Takenaka T; Yoshizumi T; Mimori K
Ann Surg Oncol; 2023 Nov; 30(12):7538-7548. PubMed ID: 37477745
[TBL] [Abstract][Full Text] [Related]
56. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
Liu B; Chen Y; Yang J
Oncotarget; 2017 Apr; 8(15):24275-24291. PubMed ID: 27903974
[TBL] [Abstract][Full Text] [Related]
57. Identification of HMGB2 associated with proliferation, invasion and prognosis in lung adenocarcinoma via weighted gene co-expression network analysis.
Qiu X; Liu W; Zheng Y; Zeng K; Wang H; Sun H; Dai J
BMC Pulm Med; 2022 Aug; 22(1):310. PubMed ID: 35962344
[TBL] [Abstract][Full Text] [Related]
58. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.
Zhang LX; Gao J; Long X; Zhang PF; Yang X; Zhu SQ; Pei X; Qiu BQ; Chen SW; Lu F; Lin K; Xu JJ; Wu YB
Mol Cancer; 2022 May; 21(1):110. PubMed ID: 35525959
[TBL] [Abstract][Full Text] [Related]
59. INHA acts as a novel and potential biomarker in lung adenocarcinoma and shapes the immune-suppressive tumor microenvironment.
Zhang X; Zhang X; Jiang D; Zheng W; Wang H; Tian Y; Cheng B
Transl Oncol; 2023 Jul; 33():101679. PubMed ID: 37105130
[TBL] [Abstract][Full Text] [Related]
60. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]